BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24890600)

  • 1. Metabolic drug-drug interaction potential of macrolactin A and 7-O-succinyl macrolactin A assessed by evaluating cytochrome P450 inhibition and induction and UDP-glucuronosyltransferase inhibition in vitro.
    Bae SH; Kwon MJ; Park JB; Kim D; Kim DH; Kang JS; Kim CG; Oh E; Bae SK
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5036-46. PubMed ID: 24890600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cytochrome P450 enzymes and uridine 5'-diphospho-glucuronosyltransferases by vicagrel in human liver microsomes: A prediction of potential drug-drug interactions.
    Liu S; Wang Z; Chan E; Zhao Y; Kang J; Zhang X; Tian X
    Chem Biol Interact; 2022 Jan; 352():109775. PubMed ID: 34910929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition.
    Zheng YF; Bae SH; Choi EJ; Park JB; Kim SO; Jang MJ; Park GH; Shin WG; Oh E; Bae SK
    Food Chem Toxicol; 2014 Jun; 68():117-27. PubMed ID: 24632066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kim JH; Kwon SS; Kong TY; Cheong JC; Kim HS; In MK; Lee HS
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28287454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate glucuronosyltransferases.
    Kim SB; Kim KS; Kim DD; Yoon IS
    Biomed Pharmacother; 2019 Feb; 110():111-117. PubMed ID: 30466000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Interaction of AB-FUBINACA with Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes and Drug Transporters.
    Kim S; Kim DK; Shin Y; Jeon JH; Song IS; Lee HS
    Molecules; 2020 Oct; 25(19):. PubMed ID: 33050066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory Effects of Aschantin on Cytochrome P450 and Uridine 5'-diphospho-glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kwon SS; Kim JH; Jeong HU; Cho YY; Oh SR; Lee HS
    Molecules; 2016 Apr; 21(5):. PubMed ID: 27128896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes.
    Kong TY; Kim JH; Kwon SS; Cheong JC; Kim HS; In MK; Lee HS
    Arch Pharm Res; 2017 Jun; 40(6):727-735. PubMed ID: 28484907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins.
    Barnes KJ; Rowland A; Polasek TM; Miners JO
    Eur J Clin Pharmacol; 2014 Sep; 70(9):1097-106. PubMed ID: 24954688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug-drug interactions.
    Lee SJ; Park JB; Kim D; Bae SH; Chin YW; Oh E; Bae SK
    Toxicol Lett; 2015 Jan; 232(2):458-65. PubMed ID: 25448279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activities of macrolactin A and 7-O-succinyl macrolactin A from Bacillus polyfermenticus KJS-2 against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus.
    Kim DH; Kim HK; Kim KM; Kim CK; Jeong MH; Ko CY; Moon KH; Kang JS
    Arch Pharm Res; 2011 Jan; 34(1):147-52. PubMed ID: 21468926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Inhibition of Human UDP-Glucuronosyl-Transferase (UGT) Isoforms by Astaxanthin, β-Cryptoxanthin, Canthaxanthin, Lutein, and Zeaxanthin: Prediction of in Vivo Dietary Supplement-Drug Interactions.
    Zheng YF; Min JS; Kim D; Park JB; Choi SW; Lee ES; Na K; Bae SK
    Molecules; 2016 Aug; 21(8):. PubMed ID: 27529203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Characterization of Ertugliflozin Metabolism by UDP-Glucuronosyltransferase and Cytochrome P450 Enzymes.
    Lapham K; Callegari E; Cianfrogna J; Lin J; Niosi M; Orozco CC; Sharma R; Goosen TC
    Drug Metab Dispos; 2020 Dec; 48(12):1350-1363. PubMed ID: 33020067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous Screening of Activities of Five Cytochrome P450 and Four Uridine 5'-Diphospho-glucuronosyltransferase Enzymes in Human Liver Microsomes Using Cocktail Incubation and Liquid Chromatography-Tandem Mass Spectrometry.
    Lee B; Ji HK; Lee T; Liu KH
    Drug Metab Dispos; 2015 Jul; 43(7):1137-46. PubMed ID: 25904760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Inhibitory Effects of APINACA on Human Major Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Drug Transporters.
    Kim S; Choi WG; Kwon M; Lee S; Cho YY; Lee JY; Kang HC; Song IS; Lee HS
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31430908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional Herbal Formulas to as Treatments for Musculoskeletal Disorders: Their Inhibitory Effects on the Activities of Human Microsomal Cytochrome P450s and UDP-glucuronosyltransferases.
    Jin SE; Seo CS; Shin HK; Ha H
    Pharmacogn Mag; 2016; 12(48):241-252. PubMed ID: 27867264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro characterization of the metabolic pathways and cytochrome P450 inhibition and induction potential of BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor.
    Hong H; Su H; Ma L; Yao M; Iyer RA; Humphreys WG; Christopher LJ
    Drug Metab Dispos; 2011 Sep; 39(9):1658-67. PubMed ID: 21673131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism-mediated drug interaction potential of HS-23, a new herbal drug for the treatment of sepsis in human hepatocytes and liver microsomes.
    Jeong HU; Lee JY; Kwon SS; Kim JH; Kim YM; Hong SW; Yeon SH; Lee SM; Cho YY; Lee HS
    Arch Pharm Res; 2015 Feb; 38(2):171-7. PubMed ID: 25052959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Inhibitory Effects of Synthetic Cannabinoid EAM-2201 on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kong TY; Kwon SS; Cheong JC; Kim HS; Kim JY; Lee HS
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29659506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors.
    den Braver-Sewradj SP; den Braver MW; Baze A; Decorde J; Fonsi M; Bachellier P; Vermeulen NPE; Commandeur JNM; Richert L; Vos JC
    Eur J Pharm Sci; 2017 Nov; 109():96-110. PubMed ID: 28778465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.